Dr. Chernew reported having equity in V-BID Health, Virta Health, and Paladin Healthcare Capital. He sits on the board of advisors for The Commonwealth Fund, Paladin Healthcare Capital, The National Institute for Health Care Management and Archway Health. He has received payment for consultancy from Janssen Pharmaceuticals, Precision Health Economics, PhRMA, Pfizer, Merck, Truven, McKinsey, University of Michigan, Anthem and the State of North Carolina, Madalena Consulting and Milliman. He has received speaking honoraria from ProHealth, Healthcare Research Analysts, AcademyHealth, Discern Health, Michigan State Medical Society, America’s Health Insurance Plans, Mathematica Policy Research, DuPage Medical Group, Ontario Hospital Association, Deutsche Bank Group, Q1 Productions, Madinah Institute for Leadership and Entrepreneurship, Hartford Healthcare, Health Information and Management Systems Society, and Teva, and has received payment for editorial services from Elsevier and Intellisphere. Dr. Chernew has research funding from The Laura and John Arnold Foundation, The Commonwealth Fund, CareFirst and MedPAC.
Last updated: 3/1/17